SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-23-001669
Filing Date
2023-02-14
Accepted
2023-02-14 09:32:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 DICE THERAPEUTICS, INC. p23-0584sc13g.htm SC 13G 61252
  Complete submission text file 0000902664-23-001669.txt   63091
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92879 | Film No.: 23623453
SIC: 2834 Pharmaceutical Preparations